RebrAIn is proud to announce its second FDA 510(k) clearance for the OptimMRI software, marking another significant milestone in our mission to revolutionize neurosurgical targeting through cutting-edge AI technology. This clearance expands our capabilities to assist in targeting the infero-lateral part of the VIM for lesioning techniques such as MR-guided Focused Ultrasound (MRgFUS) and Radiosurgery, in addition to our existing support for Deep Brain Stimulation (DBS).
Our OptimMRI software, now enhanced with a new machine learning model, continues to lead the way in providing neurosurgeons with precise, data-driven tools for optimal targeting in both DBS and lesioning procedures. This advancement underscores our commitment to delivering innovative solutions to help in optimizing planning of stereotactic and functional neurosurgery.
“Extending our reach to U.S. customers with advanced AI targeting tools is a significant step in RebrAIn’s growth and strategic transformation,” said David Caumartin, CEO of RebrAIn. “The U.S. market offers a tremendous opportunity to deliver personalized targeting solutions for neurological disorders like Essential Tremor. Our AI-driven clinical targeting capabilities are set to foster numerous collaborations across the country, enhancing treatment precision and expanding neurosurgical possibilities.”
In addition, RebrAIn’s co-founders, Prof. Emmanuel Cuny, MD, and Prof. Nejib Zemzemi, PhD, will present on “VIM Lesions in Radiosurgery and Focused Ultrasound: Assessment of the Accuracy of Two Targeting Models Based on Machine Learning” at the upcoming World Society for Stereotactic and Functional Neurosurgery (WSSFN) biennial meeting in Chicago, IL, on September 5, 2024. Their presentation will provide an in-depth look into the advancements in VIM targeting, highlighting the latest research and technology driving precision in neurosurgical interventions.
We invite attendees of the WSSFN meeting to join us at Booth #9 to explore these innovations firsthand and discuss how RebrAIn’s solutions can support their practice.
